With Industry Codes In Flux, Decoding Ethics Rules Remains A Challenge
This article was originally published in The Gray Sheet
Executive Summary
Device companies aiming to stay on the good side of federal investigators in their dealings with physicians may need to do more than adhere to the AdvaMed Code of Ethics, according to a lawyer who formerly worked at the Department of Health and Human Services Office of Inspector General
You may also be interested in...
Industry Faces Five Challenges In Climate Of Change, Says AdvaMed Chief
The upcoming presidential election and "mantra of change" has created a climate of urgency for the device industry as it continues to seek greater influence as a policy shaper
Belgium Aims To Drive Biologic Competition Through Tendering
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.
EU Bodies Agree On Ways To Future-Proof EMA Funding System
EU ministers say that implementing an appropriate fee structure that is more in line with actual costs will promote innovation in the pharmaceutical sector while ensuring “fair access” to safe and effective medicines for patients.